Skip to main navigation Skip to search Skip to main content

Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: A scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology

  • Inga Voges*
  • , Francesca Raimondi
  • , Colin J. McMahon*
  • , Lamia Ait-Ali
  • , Sonya V. Babu-Narayan
  • , René M. Botnar
  • , Barbara Burkhardt
  • , Dominik D. Gabbert
  • , Lars Grosse-Wortmann
  • , Hosan Hasan
  • , Georg Hansmann
  • , Willem A. Helbing
  • , Sylvia Krupickova
  • , Heiner Latus
  • , Nicola Martini
  • , Duarte Martins
  • , Vivek Muthurangu
  • , Tiina Ojala
  • , Pim van Ooij
  • , Kuberan Pushparajah
  • Jose Rodriguez-Palomares, Samir Sarikouch, Heynric B. Grotenhuis, F. Gerald Greil, Yohann Bohbot, Maja Cikes, Marc Dweck, Erwan Donal, Julia Grapsa, Niall Keenan, Aniela Monica Petrescu, Liliana Szabo, Fabrizio Ricci, Valtteri Uusitalo
*Corresponding author for this work
  • Kiel University
  • German Centre for Cardiovascular Research
  • Papa Giovanni XXIII Hospital
  • Children’s Health Ireland
  • National Research Council of Italy
  • G. Monastery Foundation
  • Royal Brompton and Harefield NHS Foundation Trust
  • Imperial College London
  • King's College London
  • Pontificia Universidad Católica de Chile
  • University of Zurich
  • Oregon Health and Science University
  • Hannover Medical School
  • European Pediatric Pulmonary Vascular Disease Network
  • Erasmus University Rotterdam
  • Center for Congenital Heart Disease
  • Gabriele Monasterio Foundation
  • Santa Cruz Hospital
  • University College London
  • Children's Hospital Helsinki
  • Amsterdam UMC - University of Amsterdam
  • Utrecht University
  • Evelina London Children's Healthcare
  • Instituto de Salud Carlos III
  • European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart
  • L'Hospitalet de Llobregat
  • University of Texas Southwestern Medical Center

Research output: Contribution to journalArticleAcademicpeer-review

48 Downloads (Pure)

Abstract

Cardiovascular magnetic resonance (CMR) imaging is recommended in patients with congenital heart disease (CHD) in clinical practice guidelines as the imaging standard for a large variety of diseases. As CMR is evolving, novel techniques are becoming available. Some of them are already used clinically, whereas others still need further evaluation. In this statement, the authors give an overview of relevant new CMR techniques for the assessment of CHD. Studies with reference values for these new techniques are listed in the Supplementary data online, supplement.
Original languageEnglish
Pages (from-to)e274-e294
JournalEuropean heart journal cardiovascular Imaging
Volume25
Issue number12
DOIs
Publication statusPublished - 1 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Clinical impact of novel cardiovascular magnetic resonance technology on patients with congenital heart disease: A scientific statement of the Association for European Pediatric and Congenital Cardiology and the European Association of Cardiovascular Imaging of the European Society of Cardiology'. Together they form a unique fingerprint.

Cite this